Yum, Yoonji
Park, Saeyoung
Nam, Yu Hwa
Yoon, Juhee
Song, Hyeryung
Kim, Ho Jin
Lim, Jaeseung
Jung, Sung-Chul http://orcid.org/0000-0002-3174-8965
Funding for this research was provided by:
Korean Fund for Regenerative Medicine (KFRM) grant, funded by the Korea government (22C0627L1-11)
Basic Science Research Program through the NRF (2022R1I1A01064295)
Ewha Womans University (RP-Grant 2023)
Article History
Received: 12 January 2024
Revised: 23 February 2024
Accepted: 12 March 2024
First Online: 15 April 2024
Declarations
:
: H.J.K. and J.L. are employees of Cellatoz Therapeutics, Inc.; S.-C.J. is a scientific advisory board member of Cellatoz Therapeutics, Inc.; The other authors declare no conflict of interest.
: The study protocol was approved by the Ewha Womans University Medical Center (EWUMC) institutional review board (IRB number: EUMC-2021-09-036). All the experimental procedures were reviewed and approved by the ethics committee for animal research at Ewha Woman’s University (EWHA MEDIACUC 22-005-3). Informed Consent Statement: Informed written consent was obtained from all the patients participating in the study.